Mediera Corporation (TPEX:5398)
Taiwan · Delayed Price · Currency is TWD 17.20
+0.80 (4.88%)
Nov 10, 2026, 1:30 PM CST
Mediera Market Cap
Mediera has a market cap or net worth of 850.8 million as of November 10, 2026. It is the 34,675th most valuable company in the world and the 2,079th biggest in Taiwan. Its market cap has decreased by 16.50% in one year.
Market Cap
850.80M
Enterprise Value
677.72M
Revenue
195.89M
Global Rank
Country Rank
#2,079 Taiwan
PE Ratio
174.63
ChartMarket Cap Chart
Since November 3, 2004, Mediera's market cap has increased from 257.38M to 850.80M, an increase of 230.56%. That is a compound annual growth rate of 5.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 850.80M | -33.85% |
| Dec 31, 2025 | 1.29B | 33.67% |
| Dec 31, 2024 | 962.10M | 27.54% |
| Dec 29, 2023 | 754.35M | -7.01% |
| Dec 30, 2022 | 811.23M | -19.01% |
| Dec 30, 2021 | 1.00B | 4.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tien Liang BioTech | 1.65B |
| Johnson Chemical Pharmaceutical Works | 1.60B |
| Anxo Pharmaceutical | 1.18B |
| GeneFerm Biotechnology | 1.14B |
| Excelsior Biopharma | 1.11B |
| Prince Pharmaceutical | 1.05B |
| Original BioMedicals | 965.38M |
| DV Biomed | 881.44M |